Rivanna Medical’s Accuro highlighted during AORA presentation

Michael Walter | | Radiology Business | Economics

Rivanna Medical, a medical technology company based out of Charlottesville, Va., announced that its Accuro device was recognized by Anand M. Sardesai, MD, during his presentation at the fifth annual Academy of Regional Anaesthesia (AORA) of India conference.

The presentation, which focused on advances in ultrasound technology, took place on Sept. 25.

Accuro, a handheld ultrasound device, guides clinicians as they use a needle or probe on various parts of a patient’s body. Its first commercial use is helping with the administration of spinal anesthesia into the epidural space.

“No doubt, Accuro is a disruptive, game-changing device platform technology,” John A. Williams, president and CEO of Rivanna Medical, said in a statement.

Rivanna Medical received FDA 510(k) clearance for Accuro back in July.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Radiology group cancels hospital-based business to focus on outpatient center growth
RadNet has spent over $54M on acquisitions so far in 2024
Radiology provider Akumin breaks long radio silence after emerging from bankruptcy
Doc offices more than double use of nonphysicians for interpreting medical images
Radiology vendor Agfa to cut nearly $53M in costs as medical film business dwindles
Renewed optimism that radiologist-supported bill to ease prior authorization could pass by year’s end

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.